← Back to Clinical Trials
Recruiting NCT06395636

NCT06395636 Early Detection of Infection Using the Fitbit in Pediatric Surgical Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06395636
Status Recruiting
Phase
Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Condition Appendectomy
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2025-01-07
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Infection-Prediction Algorithm

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 500 participants in total. It began in 2025-01-07 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to analyze Fitbit data to predict infection after surgery for complicated appendicitis and the effect this prediction has on clinician decision making.

Eligibility Criteria

Inclusion Criteria: * children aged 3-18 years * must be post-surgical laparoscopic appendectomy for complicated appendicitis (Appendicitis is categorized as complicated if perforation, phlegmon, or abscess was present at surgery.) Exclusion Criteria: * children who are non-ambulatory or have any pre-existing mobility limitations * children who have a doctor-ordered physical activity limit \>48 hours post-surgery * children who have a comorbidity which will impact a patient's recovery * children and/or parents who do not speak English or Spanish (Translation services beyond Spanish will not be available at this time)

Contact & Investigator

Central Contact

Fizan Abdullah, MD, PhD

✉ fabdullah@luriechildrens.org

📞 312-227-4210

Principal Investigator

Fizan Abdullah, MD, PhD

PRINCIPAL INVESTIGATOR

Ann & Robert H Lurie Children's Hospital of Chicago

Frequently Asked Questions

Who can join the NCT06395636 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 18 Years, studying Appendectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06395636 currently recruiting?

Yes, NCT06395636 is actively recruiting participants. Contact the research team at fabdullah@luriechildrens.org for enrollment information.

Where is the NCT06395636 trial being conducted?

This trial is being conducted at Chicago, United States, Chicago, United States, Maywood, United States, Winfield, United States.

Who is sponsoring the NCT06395636 clinical trial?

NCT06395636 is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. The principal investigator is Fizan Abdullah, MD, PhD at Ann & Robert H Lurie Children's Hospital of Chicago. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology